PDL BioPharma Inc (NASDAQ:PDLI) are having a rough day, after the drug maker announced the closing of its previously announced offering of convertible …
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) announced that it will receive $100 million in cash – $50 million upon deal execution late yesterday and an additional …
PDL BioPharma Inc (NASDAQ:PDLI) announced that the company has appointed Steffen Pietzke, CPA, to the position of controller and chief accounting officer. Mr.
PDL BioPharma Inc (NASDAQ:PDLI) reported financial results for the first quarter ended March 31, 2015. Total revenues for the first quarter of 2015 increased nine …
PDL BioPharma, Inc. (NASDAQ:PDLI) today announced that the adjusted conversion rate for the 3.
PDL BioPharma, Inc. (PDL or the Company) (NASDAQ:PDLI) announced that the third of three shareholder lawsuits filed in the fall of 2014, was voluntarily …